Who is sponsoring NCT03595826?

NCT03595826 is sponsored by University of KwaZulu.

What drugs are being tested in NCT03595826?

Interventions in NCT03595826: Neurostimulant pharmaceutical drugs.

What condition does NCT03595826 study?

NCT03595826 studies Attention Deficit Disorder With Hyperactivity, Developmental Coordination Disorder.

Is NCT03595826 still recruiting?

NCT03595826 is currently completed. Last updated 27 November 2020.

Last reviewed 2020-11-27 · How we verify

NCT03595826

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD)

Completed NA Last updated 27 November 2020

What this trial tests

NA trial testing Neurostimulant pharmaceutical drugs in Attention Deficit Disorder With Hyperactivity in 151 participants. Completed in 30 May 2019.

Timeline

2 May 2018

Primary endpoint
30 May 2019

30 May 2019

Quick facts

Lead sponsor	University of KwaZulu
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	151
Start date	2 May 2018
Primary completion	30 May 2019
Estimated completion	30 May 2019
Sites	1 location across South Africa

Drugs / interventions tested

Neurostimulant pharmaceutical drugs — full drug profile →

Conditions studied

Attention Deficit Disorder With Hyperactivity — all drugs for Attention Deficit Disorder With Hyperactivity →
Developmental Coordination Disorder — all drugs for Developmental Coordination Disorder →

Sponsor

University of KwaZulu

Who can join

Adults 8 to 9, any sex, with Attention Deficit Disorder With Hyperactivity or Developmental Coordination Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to establish and present the prevalence figures and demographics of the co-morbidity of ADHD and DCD. It further aims to design an exercise intervention, to be utilised in the management of the symptoms of both conditions. Furthermore, it aims at establishing the efficacy of this exercise intervention, when compared with the current and most commonly used intervention, that is: neurostimulant drugs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Attention Deficit Disorder With Hyperactivity

Currently open trials in the same condition.

NCT06974136 — tES Modalities for the Treatment of ADHD · NA · recruiting
NCT06764810 — Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Yea · recruiting
NCT05621174 — The Difference in the Mechanism of Action Between Two Brands of Dexamfetamine in Adults With ADHD · NA · active not recruiting
NCT06369714 — Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. · NA · recruiting
NCT00001246 — Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers · active not recruiting

Other University of KwaZulu trials

Trials by the same sponsor.

NCT07339462 — Feasibility and Acceptability of an Intervention to Support People With Severe Mental Illness in South Africa · NA · recruiting
NCT06516549 — Evaluation of Skipping Rope and Informational Pamphlet Among Adolescents in South Africa · NA · recruiting
NCT06429475 — Anti-Inflammatory Reliever South Africa · Phase 3 · recruiting
NCT06248190 — ENHANCE-EvideNce Led Co-created HeAlth Systems interventioNs for MLTCs CarE · NA · completed
NCT05061407 — An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Paediatric Patients Undergoing Surgery · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03595826 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of KwaZulu
Last refreshed: 27 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595826.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing